RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites
Abstract
Authors
E. De Cock S. Tao A. Urspruch A. Knoop